Café Scientifique, Thursday Evening, July 29, 2010
Topic: “Medicine’s First Therapeutic Cancer Vaccine: The Challenge, the Breakthrough, & the Future”
Speaker: Edgar Engleman, M.D., Professor of Pathology & Blood Center Director, Stanford University
Date and Time: Thursday, July 29, 7-9 p.m.
Location: Stanford Blood Center - Hillview, 3373 Hillview Avenue, Palo Alto, CA 94304
Cost: Free
Topic Description
Commonly thought to be an impossible undertaking 18 years ago, learn how Dr. Engleman and his researchers were able to utilize one of the body’s own infection fighters (a type of white blood cell known as a dendritic cell) to attack cancer. Provenge, the first commercially available vaccine to utilize this technology, was shown to extend the life of patients with end stage prostate cancer, thereby gaining FDA approval in April, 2010. Dr. Engleman will also share his latest dendritic cell research and his assessment of the future of cancer vaccines.
Speaker Bio
Clinical Focus
• Pathology
• Pathology and Laboratory Medicine
Professional Education
Residency: Stanford Hospital & Clinics, CA USA (1978)
Board Certification: Internal Medicine, American Board of Internal Medicine (1974)
Residency: UCSF Medical Center CA (1973)
Internship: Moffitt Hospital-Ucsf (1972)
Medical Education: Columbia University College of Physicians & Surgeons NJ (1971)
